Literature DB >> 24005454

Imaging spectrum of peripheral primitive neuroectodermal tumours.

Pankaj Gupta1, Smriti Hari, Sanjay Thulkar.   

Abstract

Primitive neuroectodermal tumours (PNETs) arise from pluripotent neural crest cells and are classified as either central or peripheral. Peripheral PNETs (pPNETs) arise outside the central nervous system and sympathetic chain. These rare neoplasms comprise only 1% of all sarcomas and have highly aggressive biological behaviour and dismal prognosis. Adolescents and young adults are typically affected. Only isolated case reports on pPNETs appearing in both typical and atypical sites can be found in the literature. Timely diagnosis of pPNETs is a challenge to clinicians and radiologists due to the disease's insidious onset and variable locations, coupled with the limited studies that focus on the imaging features of pPNETs. Hence, this article serves to review the imaging features of this rare tumour.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005454     DOI: 10.11622/smedj.2013155

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  4 in total

1.  Primitive neuroectodermal tumor of the prostate in a 58-year-old man: A case report.

Authors:  Da-Wei Tian; Xiao-Chun Wang; Hui Zhang; Yan Tan
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

2.  CT and clinical findings of peripheral primitive neuroectodermal tumour in children.

Authors:  Huijuan Xiao; Fengchang Bao; Hongna Tan; Bo Wang; Wei Liu; Jianbo Gao; Xianzheng Gao
Journal:  Br J Radiol       Date:  2016-02-05       Impact factor: 3.039

3.  Rapidly progressive primitive neuroectodermal tumor of the prostate: A case report and review of the literature.

Authors:  Tadamasa Shibuya; Kenichi Mori; Yasuhiro Sumino; Fuminori Sato; Hiromitsu Mimata
Journal:  Oncol Lett       Date:  2014-11-24       Impact factor: 2.967

4.  Extraskeletal Ewing's sarcoma: outcomes and CT features of endoceliac lesions.

Authors:  Zeyang Chen; Yang Jiao; Zining Liu; Jiejin Yang; Jiali Sun; Pengyuan Wang
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.